Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05458843 · ClinicalTrials.gov registry record · NA

Renal Considerations in the Heat Stress Recommendations (Aim2)

A NA study of Dehydration and Hyperthermia, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT05458843: Completed NA study of Dehydration and Hyperthermia, sponsored by Indiana University.

NCT05458843 is a NA study of Dehydration and Hyperthermia that has completed, run by Indiana University. The registered enrollment target is 18 participants, below the 57-participant average among 20 other Dehydration trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05458843, a NA study of Dehydration and Hyperthermia, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

An epidemic of chronic kidney disease is occurring in laborers who undertake physical work outdoors in hot conditions. The reason for this is largely unknown, but may be related to kidney dysfunction caused by increases in body temperature and dehydration that elicit oxidative stress and inflammation in the renal tubules. The purpose of this study is to determine whether hydration status modifies the development of renal oxidative stress and inflammation.

Primary Outcome

Marker of renal oxidative stress

Interventions

  • PROCEDURE Fluid replacement
  • PROCEDURE No fluid replacement

Study Locations (1)

Indiana

  • School of Public Health - Bloomington

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2022-08-01
Est. Completion 2023-05-22
Phase NA
Indiana University

890 total trials

What the finished NCT05458843 record still lists

NCT05458843 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 57-participant average among 20 other Dehydration trials with a reported enrollment target (68% lower).

The record links to 5 conditions, with Dehydration appearing as the primary indexed condition, and to 2 interventions - of which Fluid replacement is the first listed.

NCT05458843 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT05458843 about?

NCT05458843 is a clinical study titled "Renal Considerations in the Heat Stress Recommendations (Aim2)". An epidemic of chronic kidney disease is occurring in laborers who undertake physical work outdoors in hot conditions. The reason for this is largely unknown, but may be related to kidney dysfunction caused by increases in body temperature and dehydration that elicit oxidative stress and inflammatio...

What is the current status of trial NCT05458843?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2022-08-01. Estimated completion is 2023-05-22.

What conditions does trial NCT05458843 study?

This clinical trial studies the following conditions: Dehydration, Hyperthermia, Kidney Injury, Kidney Dysfunction, Hot Weather; Adverse Effect.

What interventions are being tested in trial NCT05458843?

The interventions under investigation include: Fluid replacement (PROCEDURE), No fluid replacement (PROCEDURE).

Who is sponsoring clinical trial NCT05458843?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05458843 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dehydration

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05458843's enrollment target sits among peer trials

18 17th of 20 higher than 4 of 20 other Dehydration trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dehydration trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05458843, the US trial registry maintained by the National Library of Medicine. NCT05458843 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.